Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Epilepsy

Interventions

DRUG

BIA 2-093

DRUG

Gliclazide

tablets containing gliclazide 80 mg (Diamicron® 80 mg)

Trial Locations (1)

Human Pharmacology Unit, S. Mamede Do Coronado

All Listed Sponsors

lead

Bial - Portela C S.A.

INDUSTRY

NCT02777671 - Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers | Biotech Hunter | Biotech Hunter